Hypofractionated preoperative radiotherapy in soft tissue sarcoma of the extremities andtrunk: outcomes from a prospective phase II study
Anastasia Stergioula | ESTRO | 2026
One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Andrei Fodor, Italy | ESTRO | 2026
Cyberknife UH-SBRT for localized Prostate cancer and DIL: preliminary report of acute and late side effects of the prospective PRO-SPEED trial
Karl Amin, Italy | ESTRO | 2026
EARLY FINDINGS FROM THE STARR (NCT05455736) TRIAL:STEREOTACTIC SALVAGE RADIOTHERAPY FOR MACROSCOPIC RECURRENCE IN THE PROSTATE BED POST-PROSTATECTOMY
Niccolo’ Bertini | ESTRO | 2026
Impact of alternating-day fractionation on treatment outcome and toxicity in CyberKnife prostate SBRT
Michaela Jindráková, Czech Republic | ESTRO | 2026
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Planning, patient QA and image-guidance aspects of single-fraction, one-Day robotic SBRT for localized prostate cancer.
SARA BROGGI, Italy | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Volumetric analysis of Vestibular Schwannoma after Cyberknife Stereotactic Radiosurgery/SBRT: single center study
Maris Mezeckis, Latvia | ESTRO | 2026
Cyberknife Stereotactic Radiosurgery For Vestibular Schwannoma: 9-Year Single-Centre Experience
Sandra Lediņa, Latvia | ESTRO | 2026
Association of initial response after stereotactic radiotherapy for symptomatic large brain metastases with neurological improvement and survival
Takayuki Sakurai | ESTRO | 2026
Dosimetric and Treatment Efficiency Comparison of IRIS versus MLC Collimators in CyberKnife Radiosurgery for Brain AVMs
Bhooshan Zade, India | ESTRO | 2026
Acoustic Neurinomas Treated with CyberKnife® SRS: Early Experience on Tolerability and Feasibility
Federica Pavoncello, Italy | ESTRO | 2026
Local control after stereotactic radiosurgery and fractionated stereotactic radiotherapy for cerebellopontine angle tumours
Łukasz Raszewsk | ESTRO | 2026
Dosimetric performance of Fixed and MLC collimators in robotic stereotactic radiosurgery for brain metastases
Anna Pederzoli, Italy | ESTRO | 2026
Integrating functional brain regions into treatment optimization: a multi-institutional dosimetric study in CyberKnife SRT for brain metastases
Feng Yang, China | ESTRO | 2026
Optimizing Treatment Planning for Acoustic Neuromas with CyberKnife SRS: Preliminary Outcome Analysis
Federica Murtas, Italy | ESTRO | 2026
Clinical outcomes and dosimetry of root entry zone-targeted radiosurgery for trigeminal neuralgia
Bhooshan Zade | ESTRO | 2026
Radiobiological dose and treatment duration influence pain relief and sensory outcomes in CyberKnife radiosurgery for trigeminal neuralgia
Evangelos Pantelis, Greece | ESTRO | 2026
